Seres Therapeutics, Inc.
MCRB
$4.54
$0.061.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.46M | -46.90M | 5.70M | 5.39M | 85.97M |
| Total Depreciation and Amortization | 11.85M | 12.24M | 12.53M | 13.46M | 13.82M |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 463.00K |
| Total Other Non-Cash Items | 15.05M | 9.83M | 10.67M | 10.47M | -109.87M |
| Change in Net Operating Assets | -55.70M | -17.32M | -27.78M | -52.38M | -50.33M |
| Cash from Operations | -51.26M | -42.15M | 1.12M | -23.06M | -59.94M |
| Capital Expenditure | -37.00K | -218.00K | -252.00K | -313.00K | -434.00K |
| Sale of Property, Plant, and Equipment | 224.00K | 210.00K | 210.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | 0.00 | 141.27M |
| Other Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Investing | 187.00K | -8.00K | -42.00K | -313.00K | 140.84M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | -127.91M |
| Issuance of Common Stock | 14.86M | 13.15M | 13.90M | 2.98M | 19.95M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.86M | 13.15M | 13.90M | 2.98M | -107.95M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -1.00K | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36.21M | -29.02M | 14.97M | -20.39M | -27.06M |